Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct;12(10):2635-2644.
doi: 10.1007/s13300-021-01143-6. Epub 2021 Aug 29.

Randomised Controlled Trials in Diabetes Research: A Pathway to Interpreting Published Results

Tadej Battelino  1   2 , Didac Mauricio  3   4
Affiliations

Randomised Controlled Trials in Diabetes Research: A Pathway to Interpreting Published Results

Tadej Battelino et al. Diabetes Ther. 2021 Oct.
No abstract available

Keywords: CONSORT; Interpretation; Publications; Randomised controlled trial.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Interpreting publications reporting results from randomised controlled trials (RCTs): a guidance checklist
See this image and copyright information in PMC

References

    1. Bolli GB, et al. New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naive people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3) Diabetes Obes Metab. 2015;17(4):386–394. doi: 10.1111/dom.12438. - DOI - PMC - PubMed
    1. Riddle MC, et al. New insulin glargine 300 units/mL versus glargine 100 units/mL in people with type 2 diabetes using basal and mealtime insulin: glucose control and hypoglycemia in a 6-month randomized controlled trial (EDITION 1) Diabetes Care. 2014;37(10):2755–2762. doi: 10.2337/dc14-0991. - DOI - PubMed
    1. Terauchi Y, et al. New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: glucose control and hypoglycaemia in a randomized controlled trial (EDITION JP 2) Diabetes Obes Metab. 2016;18(4):366–374. doi: 10.1111/dom.12618. - DOI - PMC - PubMed
    1. Bode BW, et al. Efficacy and safety of insulin degludec 200 U/mL and insulin degludec 100 U/mL in patients with type 2 diabetes (BEGIN: Compare). Endocr Pract. 2014;20(8):785–91. - PubMed
    1. Yki-Järvinen H, et al. New insulin glargine 300 units/mL versus glargine 100 units/mL in people with type 2 diabetes using oral agents and basal insulin: glucose control and hypoglycemia in a 6-month randomized controlled trial (EDITION 2) Diabetes Care. 2014;37(12):3235–3243. doi: 10.2337/dc14-0990. - DOI - PubMed

LinkOut - more resources